smaple image

Nikolay Turovets, PhD

Nikolay Turovets, PhD, is an invention scientist behind the defensin anti-aging technology and the CEO at DefenAge Skincare. Nikolay brought into DefenAge more than 20 years of expertize in drug development and scientific and clinical operations, including cancer research, stem cell therapies and IVF. Before joining DefenAge, Nikolay led scientific operations of a multi-disciplinary team of scientists at UC Irvine to obtain US FDA clearance for a clinical trial of the first drug to cure retinitis pigmentosa using high-purity live stem cells. Dr. Turovets is a key member of the first team that intentionally derived pluripotent stem cells from unfertilized human eggs which were published in Elsevier’s Encyclopedia of Human Biology.